English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 16 Help

Selected(0)Clear Items/Page:    Sort:
Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Luo, Fangcheng, Li, Haitao, Hu, Shengquan, Mingyuan Lee, Simon, Yang, Xifei, Zhang, Gaoxiao, Zhang, Zaijun, Sun, Yewei, Wang, Yuqiang. Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models[J]. Journal of Advanced Research, 2024, 64, 195-211.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Luo, Fangcheng;  Li, Haitao; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:11.4/11.0 | Submit date：2024/02/22
Nuclear Factor Erythroid-2-related Factor 2  Parkinson's Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  
Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Qiu, Xiaoling, Luo, Fangcheng, Li, Haitao, Lee, Simon Mingyuan, Yang, Xifei, Zhang, Gaoxiao, Sun, Yewei, Zhang, Zaijun, Wang, Yuqiang. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation[J]. NeuroMolecular Medicine, 2024, 26(1), 9.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Qiu, Xiaoling;  Luo, Fangcheng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.3/3.6 | Submit date：2024/05/16
Nuclear Factor Erythroid-2-related Factor 2  Parkinson’s Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  Ubiquitin–proteasome System  Α-synuclein  
Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction Journal article
Qingwen Xiao, Bingling Zhong, Ying Hou, Miaojuan Wang, Baojian Guo, Ligen Lin, Yinning Zhou, Xiuping Chen. Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction[J]. Free Radical Biology and Medicine, 2023, 202, 35-45.
Authors:  Qingwen Xiao;  Bingling Zhong;  Ying Hou;  Miaojuan Wang;  Baojian Guo; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:7.1/7.9 | Submit date：2023/07/20
Isobavachalcone  Mitochondria  Mpt-driven Necrosis  Ros  
Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease Journal article
Jing, Mei, Cen, Yun, Gao, Fangfang, Wang, Ting, Jiang, Jinxin, Jian, Qianqian, Wu, Liangmiao, Guo, Baojian, Luo, Fangcheng, Zhang, Gaoxiao, Wang, Ying, Xu, Lipeng, Zhang, Zaijun, Sun, Yewei, Wang, Yuqiang. Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease[J]. Frontiers in Pharmacology, 2021, 12, 680336.
Authors:  Jing, Mei;  Cen, Yun;  Gao, Fangfang;  Wang, Ting;  Jiang, Jinxin; et al.
Favorite | TC[WOS]:14 TC[Scopus]:15  IF:4.4/5.0 | Submit date：2021/12/08
Diabetic Kidney Disease  Metabolic Abnormalities  Mitochondrial Function  Nephroprotection  Oxidative Stress  
Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease Journal article
Mei Jing, Yun Cen, Fangfang Gao, Ting Wang, Jinxin Jiang, Qianqian Jian, Liangmiao Wu, Baojian Guo, Fangcheng Luo, Gaoxiao Zhang, Wang Y(王穎), Lipeng Xu, Zaijun Zhang, Yewei Sun, Yuqiang Wang. Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease[J]. https://doi.org/10.3389/fphar.2021.680336, 2021.
Authors:  Mei Jing;  Yun Cen;  Fangfang Gao;  Ting Wang;  Jinxin Jiang; et al.
Favorite |  | Submit date：2023/07/07
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models Journal article
Zhou,Hefeng, Shao,Min, Guo,Baojian, Li,Chuwen, Lu,Yucong, Yang,Xuanjun, ShengnanLi,, Li,Haitao, Zhu,Qi, Zhong,Hanbing, Wang,Yuqiang, Zhang,Zaijun, Lu,Jiahong, Lee,Simon Ming Yuen. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models[J]. Neurotherapeutics, 2019, 16(4), 1225-1236.
Authors:  Zhou,Hefeng;  Shao,Min;  Guo,Baojian;  Li,Chuwen;  Lu,Yucong; et al.
Favorite | TC[WOS]:26 TC[Scopus]:28  IF:5.6/6.9 | Submit date：2021/03/01
Degradation  Lmp7  Parkinson’s Disease  Proteasome Activity  Α-synuclein  
Andrographolide derivative ameliorated dextran sulfate sodium (dss)-induced experimental colitis Conference paper
Ding Moyu, Guo Baojian, Wang Y(王穎). Andrographolide derivative ameliorated dextran sulfate sodium (dss)-induced experimental colitis[C], 2019.
Authors:  Ding Moyu;  Guo Baojian;  Wang Y(王穎)
Favorite |  | Submit date：2023/08/24
Tetramethylpyrazine nitrone activates PGC-1α/Nrf2 pathway to prevent neurodegeneration in experimental models of Parkinson’s disease Conference paper
Zhang Zaijun, Guo Baojian, Zheng Chengyou, Wang Y(王穎), Lee Simon, Wang Yuqiang. Tetramethylpyrazine nitrone activates PGC-1α/Nrf2 pathway to prevent neurodegeneration in experimental models of Parkinson’s disease[C], 2018.
Authors:  Zhang Zaijun;  Guo Baojian;  Zheng Chengyou;  Wang Y(王穎);  Lee Simon; et al.
Favorite |  | Submit date：2023/08/24
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo, Baojian, Hu, Shengquan, Zheng, Chengyou, Wang, Hongyu, Luo, Fangcheng, Li, Haitao, Cui, Wei, Yang, Xifei, Cui, Guozhen, Mak, Shinghung, Choi, Tony Chung-Lit, Ma, Edmond Dik-Lung, Wang, Yuqiang, Lee, Simon Ming Yuen, Zhang, Zaijun, Han, Yifan. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. NEUROPHARMACOLOGY, 2017, 126, 12-24.
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng; et al.
View | Adobe PDF | Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.6/4.5 | Submit date：2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b  
Therapeutic efficacy and mechanistic study of tetramethylpyrazine derivative TBN on Parkinson's disease Conference paper
Guo Baojian, Zhang Zaijun, Wang Yuqiang, Wang Y(王穎). Therapeutic efficacy and mechanistic study of tetramethylpyrazine derivative TBN on Parkinson's disease[C], 2017.
Authors:  Guo Baojian;  Zhang Zaijun;  Wang Yuqiang;  Wang Y(王穎)
Favorite |  | Submit date：2023/08/24